Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
2,029 articles
Contravisory Investment Management Inc. Purchases 70,550 Shares of Merck & Co., Inc. $MRK
Contravisory Investment Management Inc. boosted its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 19,435.3% in the...
Contravisory Investment Management Inc. Purchases 70,550 Shares of Merck & Co., Inc. $MRK
Contravisory Investment Management Inc. boosted its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 19,435.3% in the...
Congress Asset Management Co. Has $121.09 Million Stock Position in Thermo Fisher Scientific Inc. $TMO
Congress Asset Management Co. raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 39.4% during the 4th quarter,...
Congress Asset Management Co. Has $121.09 Million Stock Position in Thermo Fisher Scientific Inc. $TMO
Congress Asset Management Co. raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 39.4% during the 4th quarter,...
Congress Asset Management Co. Has $121.09 Million Stock Position in Thermo Fisher Scientific Inc. $TMO
Congress Asset Management Co. raised its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 39.4% during the 4th quarter,...
5,856 Shares in AbbVie Inc. $ABBV Acquired by Clear Trail Advisors LLC
Clear Trail Advisors LLC bought a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the 4th quarter, according to its most recent...
📰
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" />
<p...
Best "Strong Buy" Momentum Stocks to Buy Now and in April
How investors can find the best "Strong Buy" momentum stocks to add to their portfolios heading into April and throughout 2026.
📰
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
CAMBRIDGE, Mass., March 24, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today...
📰
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that...
📰
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced that...
📰
Sarepta to reveal first human data for two rare muscle disease drugs - Stock Titan
Sarepta to reveal first human data for two rare muscle disease drugs Stock Titan
📰
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
Successfully dosed first three cohorts in SAD portion of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data
📰
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance
Fourth quarter 2025 total revenue of $7.3 million at the top of the range of previous preliminary announcement
UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.
Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.
Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.
Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
UnitedHealth Group Incorporated $UNH Stock Position Raised by Diversified Trust Co.
Diversified Trust Co. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.5% during the fourth quarter,...
Bill Few Associates Inc. Purchases 7,522 Shares of Abbott Laboratories $ABT
Bill Few Associates Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 21.0% in the fourth quarter,...
Assenagon Asset Management S.A. Increases Position in Abbott Laboratories $ABT
Assenagon Asset Management S.A. increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 333.5% during the 4th...
Bill Few Associates Inc. Purchases 7,522 Shares of Abbott Laboratories $ABT
Bill Few Associates Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 21.0% in the fourth quarter,...
Assenagon Asset Management S.A. Increases Position in Abbott Laboratories $ABT
Assenagon Asset Management S.A. increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 333.5% during the 4th...
Clear Trail Advisors LLC Makes New $7.97 Million Investment in Merck & Co., Inc. $MRK
Clear Trail Advisors LLC purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to...
Clear Trail Advisors LLC Makes New $7.97 Million Investment in Merck & Co., Inc. $MRK
Clear Trail Advisors LLC purchased a new stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to...
E. Ohman J or Asset Management AB Boosts Stock Holdings in Boston Scientific Corporation $BSX
E. Ohman J or Asset Management AB boosted its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 42.0% during the 4th...
E. Ohman J or Asset Management AB Boosts Stock Holdings in Boston Scientific Corporation $BSX
E. Ohman J or Asset Management AB boosted its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 42.0% during the 4th...
E. Ohman J or Asset Management AB Boosts Stock Holdings in Boston Scientific Corporation $BSX
E. Ohman J or Asset Management AB boosted its holdings in Boston Scientific Corporation (NYSE:BSX – Free Report) by 42.0% during the 4th...
📰
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF
The Vanguard International High Dividend Yield ETF holds more than 1,500 stocks and yields 3.3%.
Ondas Reloads With $1.5B Cash, Aggressive Deals And 100%+ Upside Target
Ondas Inc. (NASDAQ:ONDS) delivered record quarterly results on Monday, sharply boosting its 2026 outlook and winning an analyst price-target hike on...
AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position
BDF Gestion grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 28.9% during the fourth quarter, according to the company in its most...
Zoetis Inc. $ZTS Shares Purchased by Central Bank & Trust Co.
Central Bank & Trust Co. raised its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 54.3% in the fourth quarter, according...
AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position
BDF Gestion grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 28.9% during the fourth quarter, according to the company in its most...
AbbVie Inc. $ABBV is BDF Gestion’s 10th Largest Position
BDF Gestion grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 28.9% during the fourth quarter, according to the company in its most...
Zoetis Inc. $ZTS Shares Purchased by Central Bank & Trust Co.
Central Bank & Trust Co. raised its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 54.3% in the fourth quarter, according...
Zoetis Inc. $ZTS Shares Purchased by Central Bank & Trust Co.
Central Bank & Trust Co. raised its position in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 54.3% in the fourth quarter, according...
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
GILD expands into autoimmune therapies with an acquisition deal with Ouro Medicines, adding OM336 and advancing its push into next-gen immunology...
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
GILD expands into autoimmune therapies with an acquisition deal with Ouro Medicines, adding OM336 and advancing its push into next-gen immunology...
📰
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
GILD expands into autoimmune therapies with an acquisition deal with Ouro Medicines, adding OM336 and advancing its push into next-gen immunology...
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
GILD expands into autoimmune therapies with an acquisition deal with Ouro Medicines, adding OM336 and advancing its push into next-gen immunology...
📰
The Vanguard Fund That Can Turn $400 Per Month Into More Than $1.5 Million
Even if you're starting with $0 today, you can still build up a million-dollar portfolio with regular monthly investments.
E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD
E. Ohman J or Asset Management AB raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 22.0% in the 4th quarter,...
E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD
E. Ohman J or Asset Management AB raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 22.0% in the 4th quarter,...
E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD
E. Ohman J or Asset Management AB raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 22.0% in the 4th quarter,...
IDEXX Laboratories, Inc. $IDXX Holdings Raised by Congress Asset Management Co.
Congress Asset Management Co. increased its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 9,894.0% during the...